Wegovy works, but not on the same timeline or at the same pace for everyone. If your scale hasn’t budged or has stalled after initial progress, there are several concrete reasons why, and most of them are fixable. Understanding what’s happening in your body can help you figure out whether you need to wait it out, adjust your habits, or talk to your prescriber about your dose.
You May Not Be at the Therapeutic Dose Yet
Wegovy uses a slow dose escalation that takes at least 16 weeks before you reach the full maintenance dose. The schedule starts at 0.25 mg for the first four weeks, increases to 0.5 mg for weeks five through eight, then 1 mg, then 1.7 mg, and finally 2.4 mg from week 17 onward. If you’re still in the earlier phases, you’re on a fraction of the dose that drives significant weight loss. Many people start seeing some movement on the scale around week four, but meaningful results typically build as you approach and settle into the maintenance dose.
Some people also need to delay a dose increase because of side effects like nausea, which can push the full timeline out by a month or more. If your prescriber held you at a lower dose for tolerability reasons, that’s a legitimate explanation for slower progress. The 1.7 mg dose is also an approved maintenance option, but 2.4 mg is the recommended target for weight reduction.
Your Metabolism Has Adjusted to Your New Weight
As you lose weight, your body needs fewer calories to keep itself running. This is basic thermodynamics, but it catches people off guard. Someone who has already lost 15 or 20 pounds is burning less energy at rest than they were before, even if their eating and exercise habits haven’t changed at all. The same calorie intake that produced a deficit three months ago might now be roughly maintenance level.
On top of that, research shows that 20 to 40 percent of weight lost on semaglutide can come from lean mass, including muscle. Muscle is more metabolically active than fat, so losing it further reduces the number of calories your body burns throughout the day. This creates a compounding effect: you weigh less, you have less muscle, and your metabolism is now slower than it was when you started. None of this means the medication stopped working. It means your body adapted, and your approach may need to adapt too.
Subtle Drops in Daily Movement
When you’re eating less, your energy levels can shift in ways you don’t consciously notice. You might take fewer steps during the day, sit down more often, or skip small physical tasks you used to do without thinking. These micro-changes in non-exercise movement can meaningfully reduce the number of calories you burn over the course of a day. Tracking your step count for a week or two can reveal whether your activity has quietly drifted downward.
You’re Not Eating Enough of the Right Things
Wegovy suppresses appetite, which is its primary mechanism for weight loss. But reduced appetite doesn’t automatically mean you’re eating in a way that supports continued progress. The Mayo Clinic recommends aiming for at least 1,200 calories per day of nutrient-dense foods while on Wegovy. Going too low can backfire by accelerating muscle loss and metabolic slowdown.
Protein matters more on this medication than most people realize. Nutrition experts recommend about 0.55 grams of protein per pound of body weight each day while taking a GLP-1 medication. For someone weighing 150 pounds, that works out to roughly 82 grams of protein daily. Hitting that target helps preserve lean muscle mass, which in turn keeps your metabolism from dropping as steeply. When your appetite is suppressed and you’re eating smaller portions, it’s easy to fill up on carbs or light snacks and fall well short of that protein goal without realizing it.
Your Body Is Changing Even if the Scale Isn’t
Scale weight is a blunt instrument. Real-world clinical data shows that semaglutide reduces waist circumference by roughly 2.5 centimeters over six months and drives meaningful reductions in fat mass, blood pressure, and cholesterol. In one study, patients lost an average of about 4.7 kilograms (around 10 pounds) at six months and 5.4 kilograms at twelve months, with documented improvements in visceral fat, the deep abdominal fat linked to metabolic disease.
Preclinical research suggests semaglutide acts directly on fat cells to regulate how they store and release fat, with particular effects on visceral fat. So even during a period when your weight appears stuck, your body composition may be shifting in a meaningful direction. If your clothes fit differently, your waist measurement has dropped, or your blood work has improved, those are real results that the scale won’t capture. Tracking waist circumference with a tape measure every few weeks gives you a more complete picture than weight alone.
Insulin Resistance Can Slow the Process
If you have insulin resistance, polycystic ovary syndrome (PCOS), or type 2 diabetes, your body processes energy differently in ways that can make weight loss slower and less linear. The good news is that semaglutide directly improves insulin sensitivity while promoting weight loss. In a study of women with obesity and PCOS who hadn’t responded to lifestyle changes alone, nearly 80% achieved at least a 5% reduction in body weight after just three months on semaglutide, along with lower fasting insulin levels and better markers of insulin sensitivity.
But “slower” is the key word. People with significant insulin resistance often see the scale respond more gradually at first. As insulin sensitivity improves over weeks and months, the body becomes more efficient at using stored energy, and weight loss can accelerate. This is one situation where patience genuinely matters, because the metabolic improvements happening beneath the surface are setting the stage for further progress.
Your Stomach May Be Adapting to the Medication
One of the ways semaglutide reduces appetite is by slowing how quickly food leaves your stomach. This makes you feel full longer after eating. However, research shows that while gastric emptying is significantly delayed in the first four weeks of treatment, this effect diminishes after about 16 weeks of continuous use. It doesn’t fully return to normal, but the slowing is less dramatic than it was early on. As your stomach adapts, you may notice that meals don’t keep you as full for as long, which can lead to eating slightly more without being aware of it.
Other Medications May Be Working Against You
Several common medication classes are known to promote weight gain, and they can partially or fully offset what Wegovy is doing. Corticosteroids (like prednisone), certain antidepressants, some antipsychotics, beta-blockers, and insulin itself can all drive weight gain through increased appetite, fluid retention, or changes in how your body stores fat. If you started or increased any medication around the time your weight loss stalled, that’s worth discussing with your prescriber. In some cases, alternatives exist that are weight-neutral or even weight-favorable.
What You Can Do About a Stall
A weight loss plateau on Wegovy isn’t a sign that the medication has failed. It’s usually a sign that one or more factors need adjusting. The most impactful steps are protecting your muscle mass with adequate protein and some form of resistance exercise, keeping your daily movement levels consistent, and making sure your calorie intake is in the right range rather than just “less than before.”
If you’ve been at your maintenance dose for several months and haven’t seen any change in weight, waist circumference, or how your clothes fit, that’s a reasonable time to have a conversation with your prescriber about whether your dose needs adjusting, whether another medication is interfering, or whether an underlying metabolic condition needs closer attention. For most people, though, the stall is temporary and traceable to one of the factors above.